Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic

Antimicrobial Resistance and Infection Control

Volumn 3, Issue 1, 2014, Pages

  Taylor, Geoffrey ^a   Mitchell, Robyn ^b   Fernandes, Rachel ^b   McGeer, Allison ^c   Frenette, Charles ^d   Suh, Kathryn N ^e   Wong, Alice ^f   Katz, Kevin ^g   Wilkinson, Krista ^b   Amihod, Barbara ^h   Gravel, Denise ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f ROYAL UNIVERSITY HOSPITAL   (Canada)

^g NORTH YORK GENERAL HOSPITAL   (Canada)

^h MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; AGED; ANTIVIRAL THERAPY; ARTICLE; CANADA; CLINICAL PRACTICE; COMORBIDITY; DISEASE SEVERITY; DRUG USE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TIME TO TREATMENT;

EID: 84905563585     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-3-2     Document Type: Article

References (12)

1. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, Low D. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infec Dis 2007, 45:1568-1575.
2. Lee N, Choi KW, Chan PKS, Hui DSC, Lui GCY, Wong BCK, et al. Outcomes of adults hospitalized with severe influenza. Thorax 2010, 65:510-515. 10.1136/thx.2009.130799, 20522848.
3. Louie JK, Yang S, Acosta M, et al. Treatment with Neuraminidase inhibitors for critically ill patients with influenza A (H1N1) pdm09. Clin Infect Dis 2012, 55:1198-1204. 10.1093/cid/cis636, 22843781.
4. Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam JS. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-10 influenza A (H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis 2013, 207:553-563. 10.1093/infdis/jis726, 3549600, 23204175.
5. Influenza Antiviral Medications Summary for Clinicians; Centers for Disease Control and Prevention. Content source: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD) http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm, Influenza Antiviral Medications.
6. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1003-1032. 10.1086/598513, 19281331.
7. Aoki FY, Allen UD, Stiver HG, Evans GA. The use of antiviral drugs for influenza: guidance for practitioners 2012/2013. Can J Infect Dis Med Microbiol 2012, 23(4):e79-e92. 3597404, 24294283.
8. Doshi S, Kamimoto L, Finelli L, Perez A, Reingold A, Gershman K, et al. Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009. J Infect Dis 2011, 204:1848-1856. 10.1093/infdis/jir648, 22013219.
9. Wilkinson K, Mitchell R, Taylor G, Amihod B, Frenette C, Gravel D. Laboratory confirmed pandemic H1N1 in hospitalized adults. Infect Control Hosp Epidemiolog 2012, 33:1043-1046.
10. Aoki F, Hayden F. The beneficial effects of neuraminidase inhibitor drug therapy on severe patient outcomes during the 2009-2010 influenza A virus subtype H1N1pandemic. J Infect Dis 2013, 207:547-549. 10.1093/infdis/jis727, 23204176.
11. Garg S, Chaves S, Perez A, D'Mello T, Gersham K, Meek J, et al. Reduced influenza antiviral treatment among children and adults hospitalized with laboratory confirmed influenza in the year after the 2009 pandemic. Clin Inf Dis 2012, 55:18-21.
12. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminadase inhibitors for treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009, 339:b5106. 10.1136/bmj.b5106, 2790574, 19995812.